Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OSIR | AZN | AMGN | GILD | VRTX |
| Company | Osiris Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.99 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 19.01 | 90.48 | 329.67 | 122.37 | 457.17 |
| Low | 18.97 | 89.67 | 322.02 | 120.59 | 441.32 |
| Latest | 18.99 | 90.36 | 324.22 | 121.42 | 444.63 |
| Change | unch | +0.18 | -5.67 | +0.20 | -10.85 |
| % Change | unch | +0.20% | -1.72% | +0.16% | -2.38% |
| Volume | 455,000 | 3,006,362 | 1,252,864 | 1,926,074 | 624,582 |
| 20-Day Average Volume | 229,660 | 5,389,278 | 2,809,444 | 6,786,608 | 1,375,137 |
| Previous Close | 18.99 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.02 | 90.11 | 337.69 | 124.49 | 434.80 |
| 20-Day Raw Stochastic | 24.32% | 51.59% | 17.09% | 39.11% | 65.90% |
| 20-Day Relative Strength | 71.54 | 58.79 | 50.91 | 48.94 | 57.78 |
| Weighted Alpha | +153.30 | +38.31 | +20.87 | +29.60 | -0.34 |
| Today's Opinion | 88% Buy | 88% Buy | 80% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 04/09/19 | -0.51% since 12/01/25 | -3.96% since 12/01/25 | -2.15% since 12/01/25 | +4.71% since 12/01/25 |
| Low | 18.95 on 04/10/19 | 89.68 on 12/08/25 | 322.02 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 19.02 on 04/12/19 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | -0.37% since 03/15/19 | +6.48% since 11/07/25 | +1.23% since 11/07/25 | +2.37% since 11/07/25 | +8.84% since 11/07/25 |
| Low | 18.90 on 04/09/19 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 19.27 on 03/20/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +30.16% since 01/16/19 | +10.42% since 09/08/25 | +15.68% since 09/08/25 | +4.98% since 09/08/25 | +12.75% since 09/08/25 |
| Low | 13.56 on 02/06/19 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 19.30 on 03/11/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +82.77% since 10/16/18 | +23.57% since 06/06/25 | +11.64% since 06/06/25 | +8.18% since 06/06/25 | -1.07% since 06/06/25 |
| Low | 9.14 on 10/30/18 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 19.30 on 03/11/19 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 655,687 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 34,528 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 142,820,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 36,900,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 40,820,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 32,530,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.88 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/03/19 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |